Cancer detection using Artificial Intelligence (AI) involves leveraging advanced machine learning algorithms and techniques to identify and diagnose cancer from various medical data sources. The goal is to enhance early detection, improve diagnostic accuracy, and potentially reduce the need for invasive procedures.
Colorectal cancer (CRC) ranks as the second leading cause of cancer-related deaths and the third most prevalent malignant tumour worldwide. Early detection of CRC remains problematic due to its non-specific and often embarrassing symptoms, which patients frequently overlook or hesitate to report to clinicians. Crucially, the stage at which CRC is diagnosed significantly impacts survivability, with a survival rate of 80-95\% for Stage I and a stark decline to 10\% for Stage IV. Unfortunately, in the UK, only 14.4\% of cases are diagnosed at the earliest stage (Stage I). In this study, we propose ColonScopeX, a machine learning framework utilizing explainable AI (XAI) methodologies to enhance the early detection of CRC and pre-cancerous lesions. Our approach employs a multimodal model that integrates signals from blood sample measurements, processed using the Savitzky-Golay algorithm for fingerprint smoothing, alongside comprehensive patient metadata, including medication history, comorbidities, age, weight, and BMI. By leveraging XAI techniques, we aim to render the model's decision-making process transparent and interpretable, thereby fostering greater trust and understanding in its predictions. The proposed framework could be utilised as a triage tool or a screening tool of the general population. This research highlights the potential of combining diverse patient data sources and explainable machine learning to tackle critical challenges in medical diagnostics.




Until now, in the wake of the COVID-19 pandemic in 2019, lung diseases, especially diseases such as lung cancer and chronic obstructive pulmonary disease (COPD), have become an urgent global health issue. In order to mitigate the goal problem, early detection and accurate diagnosis of these conditions are critical for effective treatment and improved patient outcomes. To further research and reduce the error rate of hospital diagnoses, this comprehensive study explored the potential of computer-aided design (CAD) systems, especially utilizing advanced deep learning models such as U-Net. And compared with the literature content of other authors, this study explores the capabilities of U-Net in detail, and enhances the ability to simulate CAD systems through the VGG16 algorithm. An extensive dataset consisting of lung CT images and corresponding segmentation masks, curated collaboratively by multiple academic institutions, serves as the basis for empirical validation. In this paper, the efficiency of U-Net model is evaluated rigorously and precisely under multiple hardware configurations, such as single CPU, single GPU, distributed GPU and federated learning, and the effectiveness and development of the method in the segmentation task of lung disease are demonstrated. Empirical results clearly affirm the robust performance of the U-Net model, most effectively utilizing four GPUs for distributed learning, and these results highlight the potential of U-Net-based CAD systems for accurate and timely lung disease detection and diagnosis huge potential.




Magnetic Resonance Imaging (MRI) plays an important role in identifying clinically significant prostate cancer (csPCa), yet automated methods face challenges such as data imbalance, variable tumor sizes, and a lack of annotated data. This study introduces Anomaly-Driven U-Net (adU-Net), which incorporates anomaly maps derived from biparametric MRI sequences into a deep learning-based segmentation framework to improve csPCa identification. We conduct a comparative analysis of anomaly detection methods and evaluate the integration of anomaly maps into the segmentation pipeline. Anomaly maps, generated using Fixed-Point GAN reconstruction, highlight deviations from normal prostate tissue, guiding the segmentation model to potential cancerous regions. We compare the performance by using the average score, computed as the mean of the AUROC and Average Precision (AP). On the external test set, adU-Net achieves the best average score of 0.618, outperforming the baseline nnU-Net model (0.605). The results demonstrate that incorporating anomaly detection into segmentation improves generalization and performance, particularly with ADC-based anomaly maps, offering a promising direction for automated csPCa identification.
Gastrointestinal (GI) diseases represent a clinically significant burden, necessitating precise diagnostic approaches to optimize patient outcomes. Conventional histopathological diagnosis, heavily reliant on the subjective interpretation of pathologists, suffers from limited reproducibility and diagnostic variability. To overcome these limitations and address the lack of pathology-specific foundation models for GI diseases, we develop Digepath, a specialized foundation model for GI pathology. Our framework introduces a dual-phase iterative optimization strategy combining pretraining with fine-screening, specifically designed to address the detection of sparsely distributed lesion areas in whole-slide images. Digepath is pretrained on more than 353 million image patches from over 200,000 hematoxylin and eosin-stained slides of GI diseases. It attains state-of-the-art performance on 33 out of 34 tasks related to GI pathology, including pathological diagnosis, molecular prediction, gene mutation prediction, and prognosis evaluation, particularly in diagnostically ambiguous cases and resolution-agnostic tissue classification.We further translate the intelligent screening module for early GI cancer and achieve near-perfect 99.6% sensitivity across 9 independent medical institutions nationwide. The outstanding performance of Digepath highlights its potential to bridge critical gaps in histopathological practice. This work not only advances AI-driven precision pathology for GI diseases but also establishes a transferable paradigm for other pathology subspecialties.
Radiologists routinely detect and size lesions in CT to stage cancer and assess tumor burden. To potentially aid their efforts, multiple lesion detection algorithms have been developed with a large public dataset called DeepLesion (32,735 lesions, 32,120 CT slices, 10,594 studies, 4,427 patients, 8 body part labels). However, this dataset contains missing measurements and lesion tags, and exhibits a severe imbalance in the number of lesions per label category. In this work, we utilize a limited subset of DeepLesion (6\%, 1331 lesions, 1309 slices) containing lesion annotations and body part label tags to train a VFNet model to detect lesions and tag them. We address the class imbalance by conducting three experiments: 1) Balancing data by the body part labels, 2) Balancing data by the number of lesions per patient, and 3) Balancing data by the lesion size. In contrast to a randomly sampled (unbalanced) data subset, our results indicated that balancing the body part labels always increased sensitivity for lesions >= 1cm for classes with low data quantities (Bone: 80\% vs. 46\%, Kidney: 77\% vs. 61\%, Soft Tissue: 70\% vs. 60\%, Pelvis: 83\% vs. 76\%). Similar trends were seen for three other models tested (FasterRCNN, RetinaNet, FoveaBox). Balancing data by lesion size also helped the VFNet model improve recalls for all classes in contrast to an unbalanced dataset. We also provide a structured reporting guideline for a ``Lesions'' subsection to be entered into the ``Findings'' section of a radiology report. To our knowledge, we are the first to report the class imbalance in DeepLesion, and have taken data-driven steps to address it in the context of joint lesion detection and tagging.
Background: Accurate MRI-based identification of extramural vascular invasion (EVI) and mesorectal fascia invasion (MFI) is pivotal for risk-stratified management of rectal cancer, yet visual assessment is subjective and vulnerable to inter-institutional variability. Purpose: To develop and externally evaluate a multicenter, foundation-model-driven framework that automatically classifies EVI and MFI on axial and sagittal T2-weighted MRI. Methods: This retrospective study used 331 pre-treatment rectal cancer MRI examinations from three European hospitals. After TotalSegmentator-guided rectal patch extraction, a self-supervised frequency-domain harmonization pipeline was trained to minimize scanner-related contrast shifts. Four classifiers were compared: ResNet50, SeResNet, the universal biomedical pretrained transformer (UMedPT) with a lightweight MLP head, and a logistic-regression variant using frozen UMedPT features (UMedPT_LR). Results: UMedPT_LR achieved the best EVI detection when axial and sagittal features were fused (AUC = 0.82; sensitivity = 0.75; F1 score = 0.73), surpassing the Chaimeleon Grand-Challenge winner (AUC = 0.74). The highest MFI performance was attained by UMedPT on axial harmonized images (AUC = 0.77), surpassing the Chaimeleon Grand-Challenge winner (AUC = 0.75). Frequency-domain harmonization improved MFI classification but variably affected EVI performance. Conventional CNNs (ResNet50, SeResNet) underperformed, especially in F1 score and balanced accuracy. Conclusion: These findings demonstrate that combining foundation model features, harmonization, and multi-view fusion significantly enhances diagnostic performance in rectal MRI.
Early detection of cervical cancer is crucial for improving patient outcomes and reducing mortality by identifying precancerous lesions as soon as possible. As a result, the use of pap smear screening has significantly increased, leading to a growing demand for automated tools that can assist cytologists managing their rising workload. To address this, the Pap Smear Cell Classification Challenge (PS3C) has been organized in association with ISBI in 2025. This project aims to promote the development of automated tools for pap smear images classification. The analyzed images are grouped into four categories: healthy, unhealthy, both, and rubbish images which are considered as unsuitable for diagnosis. In this work, we propose a two-stage ensemble approach: first, a neural network determines whether an image is rubbish or not. If not, a second neural network classifies the image as containing a healthy cell, an unhealthy cell, or both.
Early detection of cervical cancer is crucial for improving patient outcomes and reducing mortality by identifying precancerous lesions as soon as possible. As a result, the use of pap smear screening has significantly increased, leading to a growing demand for automated tools that can assist cytologists managing their rising workload. To address this, the Pep Smear Cell Classification Challenge (PS3C) has been organized in association with ISBI in 2025. This project aims to promote the development of automated tools for pep smear images classification. The analyzed images are grouped into four categories: healthy, unhealthy, both, and rubbish images which are considered as unsuitable for diagnosis. In this work, we propose a two-stage ensemble approach: first, a neural network determines whether an image is rubbish or not. If not, a second neural network classifies the image as containing a healthy cell, an unhealthy cell, or both.
We can achieve fast and consistent early skin cancer detection with recent developments in computer vision and deep learning techniques. However, the existing skin lesion segmentation and classification prediction models run independently, thus missing potential efficiencies from their integrated execution. To unify skin lesion analysis, our paper presents the Gaussian Splatting - Transformer UNet (GS-TransUNet), a novel approach that synergistically combines 2D Gaussian splatting with the Transformer UNet architecture for automated skin cancer diagnosis. Our unified deep learning model efficiently delivers dual-function skin lesion classification and segmentation for clinical diagnosis. Evaluated on ISIC-2017 and PH2 datasets, our network demonstrates superior performance compared to existing state-of-the-art models across multiple metrics through 5-fold cross-validation. Our findings illustrate significant advancements in the precision of segmentation and classification. This integration sets new benchmarks in the field and highlights the potential for further research into multi-task medical image analysis methodologies, promising enhancements in automated diagnostic systems.




Pap smear image quality is crucial for cervical cancer detection. This study introduces an optimized hybrid approach that combines the Perona-Malik Diffusion (PMD) filter with contrast-limited adaptive histogram equalization (CLAHE) to enhance Pap smear image quality. The PMD filter reduces the image noise, whereas CLAHE improves the image contrast. The hybrid method was optimized using spider monkey optimization (SMO PMD-CLAHE). BRISQUE and CEIQ are the new objective functions for the PMD filter and CLAHE optimization, respectively. The simulations were conducted using the SIPaKMeD dataset. The results indicate that SMO outperforms state-of-the-art methods in optimizing the PMD filter and CLAHE. The proposed method achieved an average effective measure of enhancement (EME) of 5.45, root mean square (RMS) contrast of 60.45, Michelson's contrast (MC) of 0.995, and entropy of 6.80. This approach offers a new perspective for improving Pap smear image quality.